Ghost cell glaucoma after intravitreous injection of ranibizumab in proliferative diabetic retinopathy

BACKGROUND: The development of ghost cell glaucoma in patients with proliferative diabetic retinopathy (PDR) after intravitreous injection (IV) was rare. Here we reported a series of patients with PDR who received Intravitreous Ranibizumab (IVR) and developed ghost cell glaucoma and analyzed the pot...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jun, Zhao, Meng, Li, Ji peng, Liu, Ning pu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161240/
https://www.ncbi.nlm.nih.gov/pubmed/32295566
http://dx.doi.org/10.1186/s12886-020-01422-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161240/
https://www.ncbi.nlm.nih.gov/pubmed/32295566
http://dx.doi.org/10.1186/s12886-020-01422-z

Ejemplares similares